19/March/2022 Top Medical Bulletin Dr. Nandita Mohan19 March 2022 6:15 PM ISTHere are top medical stories for today:Intensive blood pressure control associated with cerebral blood flow The association of intensive...
RAS inhibitors, beta-blockers after discharge improve outcomes in MI with mid-range EF: Study Medha Baranwal19 March 2022 10:15 AM ISTSouth Korea: The medical therapy with beta-blockers or RAS inhibitors at discharge is tied to better 2-year clinical outcomes in patients with mildly...
Renal transplantation reduces risk of CV events in patients of ANCA-associated vasculitis and ESRD Dr. Shravani Dali28 Feb 2022 9:00 AM ISTMyocardial infarction and ischemic stroke are leading causes of cardiovascular (CV) morbidity and mortality in ANCA-associated vasculitis (AAV), ...
Rivaroxaban to prevent clinical outcomes in covid 19 patients: MICHELLE TRIAL MD Editorial Team19 Feb 2022 9:00 AM ISTCovid-19 also known SARS Cov-2 is popularly known to cause more fatal events where severe respiratory problems and multi organ failure in the infected...
Routine invasive therapy does not reduce major ischemic events: ISCHEMIA Trial MD Editorial Team16 Feb 2022 9:00 AM ISTIschemia is a serious concern as some part of the body, vital organs such as heart or brain, isn't getting enough blood. Approximately 1.5 million...
Cardiogenic shock a serious risk of heart attack Dr. Nandita Mohan15 Feb 2022 5:51 PM ISTHeart attacks are the leading cause of death, many factors influence heart attack lifestyle, habits but cardiogenic shock is a life-threatening...
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 5:44 PM ISTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
14/February/2022 Top Medical Bulletin Dr. Nandita Mohan14 Feb 2022 5:45 PM ISTHere are today's top medical storiesCardiogenic shock to increase the risks of myocardial infarctionCardiogenic shock is a serious concern and...
ISCHEMIA Trial: Routine invasive therapy does not reduce MACE Dr. Nandita Mohan11 Feb 2022 7:11 PM IST The ISCHEMIA trial fails at proving that routine invasive therapy was associated with a reduction in major adverse ischemic events compared with...
PARADISE MI Trial: sacubitril/valsartan effective for heart attack Dr. Nandita Mohan11 Feb 2022 6:33 PM ISTThe PARADISE -MI trial assesed the efficacy and safety of sacubitril/valsartan compared with ramipril in a contemporary acute myocardial...
Rivaroxiban effective in treating COVID 19 patients: MICHELLE Trial Dr. Nandita Mohan8 Feb 2022 5:53 PM ISTThe covid pandemic has rained its havoc in the entire world. Millions of patients died and many more were discharged worldwide. Excessive...
3/February/2022 Top Medical Bulletin Dr. Nandita Mohan3 Feb 2022 5:44 PM ISTHere are todays top medical stories:Diabetes a serious risk of heart failure Diabetes and cardiac diseases go hand in hand, Hyperglycemia,...
